Victor Cee Phones & Addresses
-
2881 Capella Way #5, Thousand Oaks, CA 91362 (805) 208-9435
-
Newbury Park, CA
-
750 Kensington Ave, Salt Lake City, UT 84105
-
1761 Creek Rd #A, Sandy, UT 84093
-
41 Main St, Mansfield, MA 02048 (508) 337-3614
-
41 N Main St #2, Mansfield, MA 02048 (508) 337-3614
-
Arlington, MA
-
Cambridge, MA
-
Ventura, CA
-
750 Kensington Ave, Salt Lake City, UT 84105 (508) 337-3614
Work
Position:
Machine Operators, Assemblers, and Inspectors Occupations
Education
Degree:
Graduate or professional degree
Publications
Us Patents
Aurora Kinase Modulators And Method Of Use
View pageUS Patent:
7776857, Aug 17, 2010
Filed:
Apr 3, 2008
Appl. No.:
12/080669
Inventors:
Victor Cee - Thousand Oaks CA, US
Holly Deak - Brookline MA, US
Bingfan Du - Cambridge MA, US
Stephanie Geuns-Meyer - Medford MA, US
Brian L. Hodous - Cambridge MA, US
Zihao Hua - Tewksbury MA, US
Matthew Martin - Cambridge MA, US
Isaac Marx - Somerville MA, US
Hanh Nho Nguyen - Arlington MA, US
Philip Olivieri - Charlestown MA, US
Kathleen Panter - Cambridge MA, US
Karina Romero - Cambridge MA, US
Laurie Schenkel - Boston MA, US
Ryan White - Somerville MA, US
Holly Deak - Brookline MA, US
Bingfan Du - Cambridge MA, US
Stephanie Geuns-Meyer - Medford MA, US
Brian L. Hodous - Cambridge MA, US
Zihao Hua - Tewksbury MA, US
Matthew Martin - Cambridge MA, US
Isaac Marx - Somerville MA, US
Hanh Nho Nguyen - Arlington MA, US
Philip Olivieri - Charlestown MA, US
Kathleen Panter - Cambridge MA, US
Karina Romero - Cambridge MA, US
Laurie Schenkel - Boston MA, US
Ryan White - Somerville MA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07D 237/30
US Classification:
514248, 544237, 546123
Abstract:
The present invention relates to chemical compounds having a general formula I.
Heteroaryl-Substituted Alkyne Compounds And Method Of Use
View pageUS Patent:
7776869, Aug 17, 2010
Filed:
Oct 14, 2005
Appl. No.:
11/251490
Inventors:
Stuart C. Chaffee - Cambridge MA, US
Brian K. Albrecht - Cambridge MA, US
Brian L. Hodous - Cambridge MA, US
Matthew W. Martin - Arlington MA, US
David C. McGowan - Woluwe Street Pierre, BE
Erin F. DiMauro - Cambridge MA, US
Gade Reddy - Newbury Park CA, US
Victor J. Cee - Mansfield MA, US
Philip R. Olivieri - Medford MA, US
Anthony Reed - Oxnard CA, US
Karina Romero - Cambridge MA, US
Brian K. Albrecht - Cambridge MA, US
Brian L. Hodous - Cambridge MA, US
Matthew W. Martin - Arlington MA, US
David C. McGowan - Woluwe Street Pierre, BE
Erin F. DiMauro - Cambridge MA, US
Gade Reddy - Newbury Park CA, US
Victor J. Cee - Mansfield MA, US
Philip R. Olivieri - Medford MA, US
Anthony Reed - Oxnard CA, US
Karina Romero - Cambridge MA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07D 239/38
C07D 239/42
A61K 31/505
A61K 31/506
A61P 35/00
C07D 239/42
A61K 31/505
A61K 31/506
A61P 35/00
US Classification:
514269, 514275, 544299, 544309, 544317, 544320, 544321, 544323, 544324
Abstract:
The present invention comprises a new class of compounds useful for the prophylaxis and treatment of protein kinase mediated diseases, including inflammation, cancer and related conditions. The compounds have a general Formula I.
S1P1 Receptor Agonists And Use Thereof
View pageUS Patent:
7842685, Nov 30, 2010
Filed:
Jun 18, 2009
Appl. No.:
12/456687
Inventors:
Victor J. Cee - Thousand Oaks CA, US
Michael J. Frohn - Thousand Oaks CA, US
Brian Alan Lanman - Oak Park CA, US
Susana C. Neira - Naperville IL, US
Anthony B. Reed - Thousand Oaks CA, US
Kelvin K. C. Sham - Thousand Oaks CA, US
Michael J. Frohn - Thousand Oaks CA, US
Brian Alan Lanman - Oak Park CA, US
Susana C. Neira - Naperville IL, US
Anthony B. Reed - Thousand Oaks CA, US
Kelvin K. C. Sham - Thousand Oaks CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/397
A61K 31/4365
C07D 513/04
A61K 31/4365
C07D 513/04
US Classification:
51421018, 514301, 546114
Abstract:
The present invention relates to compounds of Formula (I):.
Multi-Cyclic Compounds And Method Of Use
View pageUS Patent:
7868177, Jan 11, 2011
Filed:
Feb 21, 2007
Appl. No.:
11/709994
Inventors:
Victor J. Cee - Thousand Oaks CA, US
Holly L. Deak - Brookline MA, US
Stephanie D. Geuns-Meyer - Medford MA, US
Brian L. Hodous - Cambridge MA, US
Hanh Nho Nguyen - Arlington MA, US
Philip R. Olivieri - Medford MA, US
Vinod F. Patel - Acton MA, US
Karina Romero - Cambridge MA, US
Holly L. Deak - Brookline MA, US
Stephanie D. Geuns-Meyer - Medford MA, US
Brian L. Hodous - Cambridge MA, US
Hanh Nho Nguyen - Arlington MA, US
Philip R. Olivieri - Medford MA, US
Vinod F. Patel - Acton MA, US
Karina Romero - Cambridge MA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07D 401/14
C07D 403/14
A61K 31/4427
A61K 31/506
A61K 31/53
A61P 19/02
A61P 35/00
C07D 403/14
A61K 31/4427
A61K 31/506
A61K 31/53
A61P 19/02
A61P 35/00
US Classification:
5462681, 546288, 514341, 514345, 514269, 514275, 514241, 544242, 544180
Abstract:
The present invention relates to chemical compounds having a general formula I.
Protein Kinase Modulators And Method Of Use
View pageUS Patent:
7880000, Feb 1, 2011
Filed:
May 9, 2005
Appl. No.:
11/126000
Inventors:
Stephanie D. Geuns-Meyer - Medford MA, US
Brian L. Hodous - Cambridge MA, US
Stuart C. Chaffee - Cambridge MA, US
Paul A. Tempest - Brookline MA, US
Philip R. Olivieri - Medford MA, US
Rebecca E. Johnson - Arlington VA, US
Brian K. Albrecht - Cambridge MA, US
Vinod F. Patel - Acton MA, US
Victor J. Cee - Mansfield MA, US
Joseph L. Kim - Wayland MA, US
Steven Bellon - Wellesley MA, US
Xiaotian Zhu - Newton MA, US
Yuan Cheng - Newbury Park CA, US
Ning Xi - Thousand Oaks CA, US
Karina Romero - Cambridge MA, US
Hanh Nho Nguyen - Arlington MA, US
Holly L. Deak - Brookline MA, US
Brian L. Hodous - Cambridge MA, US
Stuart C. Chaffee - Cambridge MA, US
Paul A. Tempest - Brookline MA, US
Philip R. Olivieri - Medford MA, US
Rebecca E. Johnson - Arlington VA, US
Brian K. Albrecht - Cambridge MA, US
Vinod F. Patel - Acton MA, US
Victor J. Cee - Mansfield MA, US
Joseph L. Kim - Wayland MA, US
Steven Bellon - Wellesley MA, US
Xiaotian Zhu - Newton MA, US
Yuan Cheng - Newbury Park CA, US
Ning Xi - Thousand Oaks CA, US
Karina Romero - Cambridge MA, US
Hanh Nho Nguyen - Arlington MA, US
Holly L. Deak - Brookline MA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07D 401/14
C07D 403/14
A61K 31/53
A61K 31/4427
A61K 31/506
A61P 19/02
A61P 35/00
C07D 403/14
A61K 31/53
A61K 31/4427
A61K 31/506
A61P 19/02
A61P 35/00
US Classification:
544320, 544322, 544182, 514272, 514274, 514242
Abstract:
The present invention relates to chemical compounds having a general formula I.
S1P Receptor Modulating Compounds And Use Thereof
View pageUS Patent:
7919519, Apr 5, 2011
Filed:
Mar 21, 2007
Appl. No.:
11/726351
Inventors:
Roland Burli - Pasadena CA, US
Victor J. Cee - Thousand Oaks CA, US
Jennifer Golden - Simi Valley CA, US
Brian Alan Lanman - Oak Park CA, US
Susana Neira - Thousand Oaks CA, US
Ashis Saha - Stow MA, US
Nili Schutz - Tel-Aviv, IL
Xiang Yu - Acton MA, US
Dilara McCauley - Cambridge MA, US
Mercedes Lobera - Bolton MA, US
Yael Marantz - Kadima, IL
Jian Lin - Walpole MA, US
Srinivasa R. Cheruku - Lexington MA, US
Pini Orbach - Needham MA, US
Anurag Sharadendu - Washington DC, US
Robert C. Penland - Watertown MA, US
Kimberley Gannon - Watertown MA, US
Sharon Shacham - Newton MA, US
Silvia Noiman - Herzliyya, IL
Oren Becker - Mevaseret Zion, IL
Zhaoda Zhang - Andover MA, US
Victor J. Cee - Thousand Oaks CA, US
Jennifer Golden - Simi Valley CA, US
Brian Alan Lanman - Oak Park CA, US
Susana Neira - Thousand Oaks CA, US
Ashis Saha - Stow MA, US
Nili Schutz - Tel-Aviv, IL
Xiang Yu - Acton MA, US
Dilara McCauley - Cambridge MA, US
Mercedes Lobera - Bolton MA, US
Yael Marantz - Kadima, IL
Jian Lin - Walpole MA, US
Srinivasa R. Cheruku - Lexington MA, US
Pini Orbach - Needham MA, US
Anurag Sharadendu - Washington DC, US
Robert C. Penland - Watertown MA, US
Kimberley Gannon - Watertown MA, US
Sharon Shacham - Newton MA, US
Silvia Noiman - Herzliyya, IL
Oren Becker - Mevaseret Zion, IL
Zhaoda Zhang - Andover MA, US
Assignee:
Epix Pharmaceuticals Inc. - Lexington MA
International Classification:
A61K 31/404
A61K 31/381
A61K 31/343
C07D 209/12
C07D 333/56
C07D 307/80
A61K 31/381
A61K 31/343
C07D 209/12
C07D 333/56
C07D 307/80
US Classification:
514419, 514443, 514469, 548494, 549 58, 549469
Abstract:
The present invention relates to compounds of the general formula (I) that have activity as S1P receptor modulating agents and the use of such compounds to treat diseases associated with inappropriate S1P receptor activity. The compounds may be used as immunomodulators, e. g. , for treating or preventing diseases such as autoimmune and related immune disorders including systemic lupus erythematosus, inflammatory bowel diseases such as Crohn's disease and ulcerative colitis, type I diabetes, uveitis, psoriasis, myasthenia gravis, rheumatoid arthritis, non-glomerular nephrosis, hepatitis, Behçet's disease, glomerulonephritis, chronic thrombocytopenic purpura, hemolytic anemia, hepatitis and Wegner's granuloma; and for treating other conditions.
Aurora Kinase Modulators And Method Of Use
View pageUS Patent:
8022221, Sep 20, 2011
Filed:
Feb 12, 2009
Appl. No.:
12/378426
Inventors:
Victor J. Cee - Thousand Oaks CA, US
Holly L. Deak - Brookline MA, US
Bingfan Du - Cambridge MA, US
Stephanie D. Geuns-Meyer - Medford MA, US
Brian L. Hodous - Cambridge MA, US
Hanh Nho Nguyen - Arlington MA, US
Philip R. Olivieri - Medford MA, US
Vinod F. Patel - Acton MA, US
Karina Romero - Cambridge MA, US
Laurie Schenkel - Boston MA, US
Holly L. Deak - Brookline MA, US
Bingfan Du - Cambridge MA, US
Stephanie D. Geuns-Meyer - Medford MA, US
Brian L. Hodous - Cambridge MA, US
Hanh Nho Nguyen - Arlington MA, US
Philip R. Olivieri - Medford MA, US
Vinod F. Patel - Acton MA, US
Karina Romero - Cambridge MA, US
Laurie Schenkel - Boston MA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07D 401/14
C07D 403/14
A61K 31/53
A61K 31/4427
A61K 31/506
A61P 19/02
A61P 35/00
C07D 403/14
A61K 31/53
A61K 31/4427
A61K 31/506
A61P 19/02
A61P 35/00
US Classification:
5462681, 546288, 514345, 514341, 514242, 514272, 514274, 514241, 514245, 51425201, 51425202, 5142521, 514256, 514269, 514275, 514277, 514336, 514340, 514348, 544182, 544320, 544322, 544408, 544180, 544209, 544219, 544238, 544239, 544240, 544295, 544297, 544310, 544317, 544324, 544328, 544331, 544405
Abstract:
The present invention relates to chemical compounds having a general formula I.
S1P Receptor Modulating Compounds And Use Thereof
View pageUS Patent:
8080542, Dec 20, 2011
Filed:
Sep 19, 2008
Appl. No.:
12/234514
Inventors:
Susana C. Neira - Thousand Oaks CA, US
Xiang Yu - Acton MA, US
Roland Burli - Bishop's Stortford, GB
Victor Cee - Thousand Oaks CA, US
Brian Lanman - Oak Park CA, US
Xiang Yu - Acton MA, US
Roland Burli - Bishop's Stortford, GB
Victor Cee - Thousand Oaks CA, US
Brian Lanman - Oak Park CA, US
Assignee:
Amgen, Inc. - Thousand Oaks CA
Epix Pharmaceuticals, Inc. - Lexington MA
Epix Pharmaceuticals, Inc. - Lexington MA
International Classification:
A61K 31/397
C07D 205/04
C07D 205/04
US Classification:
51421017, 548953
Abstract:
The present invention relates to amides that have activity as SIP receptor modulating agents and the use of such compounds to treat diseases associated with inappropriate S1P receptor activity. The compounds may be used as immunomodulators, e. g. , for treating or preventing diseases such as autoimmune and related immune disorders including systemic lupus erythematosus, inflammatory bowel diseases such as Crohn's disease and ulcerative colitis, type I diabetes, uveitis, psoriasis, myasthenia gravis, rheumatoid arthritis, non-glomerular nephrosis, hepatitis, Behçet's disease, glomerulonephritis, chronic thrombocytopenic purpura, hemolytic anemia, hepatitis and Wegner's granuloma; and for treating other conditions.